Compare Novartis AG (NVS) vs BlackRock TCP Capital Corp (TCPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs BlackRock TCP Capital Corp — how do they compare? Novartis AG trades at $152.38 (market cap $295.37B), while BlackRock TCP Capital Corp trades at $3.93 (market cap $327.64M). The key difference: Novartis AG is far larger — about 901.5× BlackRock TCP Capital Corp's market cap, and BlackRock TCP Capital Corp pays the higher dividend (19.46%). Which is the better fit depends on your goals.
| NVS | TCPC | |
|---|---|---|
Market Cap | $295.37B | $327.64M |
Sector | Health | Financials |
52-Week High | $168.62 | $7.26 |
52-Week Low | $119.31 | $3.13 |
Enterprise Value | $336.69B | — |
Dividend Yield | 3.07% | 19.46% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About BlackRock TCP Capital Corp
BlackRock TCP Capital Corp is a finance company specializing in middle-market lending. It aims for high returns through income and capital appreciation while prioritizing principal protection. The company invests in debt securities and earns revenue from interest payments, fees, and some equity appreciation.
Read more on TCPC →
